<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">radioelectronics</journal-id><journal-title-group><journal-title xml:lang="ru">Известия высших учебных заведений России. Радиоэлектроника</journal-title><trans-title-group xml:lang="en"><trans-title>Journal of the Russian Universities. Radioelectronics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1993-8985</issn><issn pub-type="epub">2658-4794</issn><publisher><publisher-name>Saint Petersburg Electrotechnical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.32603/1993-8985-2022-25-4-116-122</article-id><article-id custom-type="elpub" pub-id-type="custom">radioelectronics-667</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПРИБОРЫ МЕДИЦИНСКОГО НАЗНАЧЕНИЯ, КОНТРОЛЯ СРЕДЫ, ВЕЩЕСТВ, МАТЕРИАЛОВ И ИЗДЕЛИЙ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>MEDICAL DEVICES, ENVIRONMENT, SUBSTANCES, MATERIAL AND PRODUCT</subject></subj-group></article-categories><title-group><article-title>Machine Learning System for Predicting Cardiovascular Disorders in Diabetic Patients</article-title><trans-title-group xml:lang="en"><trans-title>Machine Learning System for Predicting Cardiovascular Disorders in Diabetic Patients</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4806-8587</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Mayya</surname><given-names>А.</given-names></name><name name-style="western" xml:lang="en"><surname>Mayya</surname><given-names>A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ali Mayya, Master student at the Department of Bioengineering Systems of Saint Petersburg Electrotechnical University, Bachelor (2019) in Electromechanics – Mechatronics of Tishreen University</p><p>Tishreen University, Southern Entrance, Latakia</p><p> </p></bio><bio xml:lang="en"><p>Ali Mayya, Master student at the Department of Bioengineering Systems of Saint Petersburg Electrotechnical University, Bachelor (2019) in Electromechanics – Mechatronics of Tishreen University</p><p>Tishreen University, Southern Entrance, Latakia</p></bio><email xlink:type="simple">alimayya1357@gmail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9868-8960</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Solieman</surname><given-names>Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Solieman</surname><given-names>H.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Hanadi Solieman, Postgraduate student, Assistant at the Department of Bioengineering Systems of Saint Petersburg Electrotechnical University, Assistant at the Mechatronics program for Distinguished of Tishreen University</p><p>Tishreen University, Southern Entrance, Latakia</p></bio><bio xml:lang="en"><p>Hanadi Solieman, Postgraduate student, Assistant at the Department of Bioengineering Systems of Saint Petersburg Electrotechnical University, Assistant at the Mechatronics program for Distinguished of Tishreen University</p><p>Tishreen University, Southern Entrance, Latakia</p><p> </p></bio><email xlink:type="simple">khsoliman@stud.etu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Saint Petersburg Electrotechnical University;&#13;
Tishreen University</institution><country>Сирия</country></aff><aff xml:lang="en"><institution>Saint Petersburg Electrotechnical University;&#13;
Tishreen University</institution><country>Syrian Arab Republic</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>29</day><month>09</month><year>2022</year></pub-date><volume>25</volume><issue>4</issue><fpage>116</fpage><lpage>122</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Mayya А., Solieman Н., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Mayya А., Solieman Н.</copyright-holder><copyright-holder xml:lang="en">Mayya A., Solieman H.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://re.eltech.ru/jour/article/view/667">https://re.eltech.ru/jour/article/view/667</self-uri><abstract><sec><title>Introduction</title><p>Introduction. Patients with diabetes are exposed to various cardiovascular risk factors, which lead to an increased risk of cardiac complications. Therefore, the development of a diagnostic system for diabetes and cardiovascular disease (CVD) is a relevant research task. In addition, the identification of the most significant indicators of both diseases may help physicians improve treatment, speed the diagnosis, and decrease its computational costs.</p></sec><sec><title>Aim</title><p>Aim. To classify subjects with different diabetes types, predict the risk of cardiovascular diseases in diabetic patients using machine learning methods by finding the correlational indicators.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The NHANES database was used following preprocessing and balancing its data. Machine learning methods were used to classify diabetes based on physical examination data and laboratory data. Feature selection methods were used to derive the most significant indicators for predicting CVD risk in diabetic patients. Performance optimization of the developed classification and prediction models was carried out based on different evaluation metrics.</p></sec><sec><title>Results</title><p>Results. The developed model (Random Forest) achieved the accuracy of 93.1 % (based on laboratory data) and 88 % (based on pysicical examination plus laboratory data). The top five most common predictors in diabetes and prediabetes were found to be glycohemoglobin, basophil count, triglyceride level, waist size, and body mass index (BMI). These results seem logical, since glycohemoglobin is commonly used to check the amount of glucose (sugar) bound to the hemoglobin in the red blood cells. For CVD patients, the most common predictors inlcude eosinophil count (indicative of blood diseases), gamma-glutamyl transferase (GGT), glycohemoglobin, overall oral health, and hand stiffness.</p></sec><sec><title>Conclusion</title><p>Conclusion. Balancing the dataset and deleting NaN values improved the performance of the developed models. The RFC and XGBoost models achieved higher accuracy using gradient descending order to minimize the loss function. The final prediction is made using a weighted majority vote of all the decisions. The result was an automated system for predicting CVD risk in diabetic patients.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Patients with diabetes are exposed to various cardiovascular risk factors, which lead to an increased risk of cardiac complications. Therefore, the development of a diagnostic system for diabetes and cardiovascular disease (CVD) is a relevant research task. In addition, the identification of the most significant indicators of both diseases may help physicians improve treatment, speed the diagnosis, and decrease its computational costs.</p></sec><sec><title>Aim</title><p>Aim. To classify subjects with different diabetes types, predict the risk of cardiovascular diseases in diabetic patients using machine learning methods by finding the correlational indicators.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The NHANES database was used following preprocessing and balancing its data. Machine learning methods were used to classify diabetes based on physical examination data and laboratory data. Feature selection methods were used to derive the most significant indicators for predicting CVD risk in diabetic patients. Performance optimization of the developed classification and prediction models was carried out based on different evaluation metrics.</p></sec><sec><title>Results</title><p>Results. The developed model (Random Forest) achieved the accuracy of 93.1 % (based on laboratory data) and 88 % (based on pysicical examination plus laboratory data). The top five most common predictors in diabetes and prediabetes were found to be glycohemoglobin, basophil count, triglyceride level, waist size, and body mass index (BMI). These results seem logical, since glycohemoglobin is commonly used to check the amount of glucose (sugar) bound to the hemoglobin in the red blood cells. For CVD patients, the most common predictors inlcude eosinophil count (indicative of blood diseases), gamma-glutamyl transferase (GGT), glycohemoglobin, overall oral health, and hand stiffness.</p></sec><sec><title>Conclusion</title><p>Conclusion. Balancing the dataset and deleting NaN values improved the performance of the developed models. The RFC and XGBoost models achieved higher accuracy using gradient descending order to minimize the loss function. The final prediction is made using a weighted majority vote of all the decisions. The result was an automated system for predicting CVD risk in diabetic patients.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>cardiovascular disorders</kwd><kwd>diabetes</kwd><kwd>machine learning</kwd><kwd>preprocessing</kwd><kwd>feature selection</kwd><kwd>methods evaluation</kwd><kwd>correlational analysis</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cardiovascular disorders</kwd><kwd>diabetes</kwd><kwd>machine learning</kwd><kwd>preprocessing</kwd><kwd>feature selection</kwd><kwd>methods evaluation</kwd><kwd>correlational analysis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Benjamin E. J., Blaha M. J., Chiuve S. E. et al. Heart Disease and Stroke Statistics – 2017 Update. Circulation. 2017, vol. 135, no. 10, pp. e146–e603. doi: 10.1161/CIR.0000000000000485</mixed-citation><mixed-citation xml:lang="en">Benjamin E. J., Blaha M. J., Chiuve S. E. et al. Heart Disease and Stroke Statistics – 2017 Update. Circulation. 2017, vol. 135, no. 10, pp. e146–e603. doi: 10.1161/CIR.0000000000000485</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Dinh A., Miertschin S., Young A., Mohanty S. D. A Data-Driven Approach to Predicting Diabetes and Cardiovascular Disease with Machine Learning. BMC Medical Informatics and Decision Making. 2019, vol. 19, no. 1, p. 211.</mixed-citation><mixed-citation xml:lang="en">Dinh A., Miertschin S., Young A., Mohanty S. D. A Data-Driven Approach to Predicting Diabetes and Cardiovascular Disease with Machine Learning. BMC Medical Informatics and Decision Making. 2019, vol. 19, no. 1, p. 211.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Dounias G., Vemmos K., Alexopoulos E. Medical Diagnosis Of Stroke Using Inductive Machine Learning. Machine Learning and Applications. 1999, 4 p.</mixed-citation><mixed-citation xml:lang="en">Dounias G., Vemmos K., Alexopoulos E. Medical Diagnosis Of Stroke Using Inductive Machine Learning. Machine Learning and Applications. 1999, 4 p.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Flint A. J., Rexrode K. M., Hu F. B., Glynn R. J., Caspard H., Manson J. E., Willet W. C., Rimm E. B. Body Mass Index, Waist Circumference, and Risk of Coronary Heart Disease: A Prospective Study Among Men and Women. Obes Res Clin Pract. 2010, vol. 4, no. 3, pp. e171– e181. doi: 10.1016/j.orcp.2010.01.001</mixed-citation><mixed-citation xml:lang="en">Flint A. J., Rexrode K. M., Hu F. B., Glynn R. J., Caspard H., Manson J. E., Willet W. C., Rimm E. B. Body Mass Index, Waist Circumference, and Risk of Coronary Heart Disease: A Prospective Study Among Men and Women. Obes Res Clin Pract. 2010, vol. 4, no. 3, pp. e171– e181. doi: 10.1016/j.orcp.2010.01.001</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Khaw K.-T., Wareham N. Glycated Hemoglobin as a Marker of Cardiovascular Risk. Curr Opin Lipidol. 2006, vol. 17, no. 6, pp. 637–643. doi: 10.1097/MOL.0b013e3280106b95</mixed-citation><mixed-citation xml:lang="en">Khaw K.-T., Wareham N. Glycated Hemoglobin as a Marker of Cardiovascular Risk. Curr Opin Lipidol. 2006, vol. 17, no. 6, pp. 637–643. doi: 10.1097/MOL.0b013e3280106b95</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Leon B. M., Maddox T. M. Diabetes and Cardiovascular Disease: Epidemiology, Biological Mechanisms, Treatment Recommendations and Future Research. World J Diabetes. 2015, vol. 6, no. 13, pp. 1246–1258. doi: 10.4239/wjd.v6.i13.1246</mixed-citation><mixed-citation xml:lang="en">Leon B. M., Maddox T. M. Diabetes and Cardiovascular Disease: Epidemiology, Biological Mechanisms, Treatment Recommendations and Future Research. World J Diabetes. 2015, vol. 6, no. 13, pp. 1246–1258. doi: 10.4239/wjd.v6.i13.1246</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">National Academies of Sciences, Engineering and Medicine; Health and Medicine Division; Food and Nutrition Board; Committee to Review the Dietary Reference Intakes for Sodium and Potassium. Dietary Reference Intakes for Sodium and Potassium. Ed. by Oria M., Harrison M., Stallings V. A. Washington (DC), National Academies Press, 2019, 594 p. doi: 10.17226/25353</mixed-citation><mixed-citation xml:lang="en">National Academies of Sciences, Engineering and Medicine; Health and Medicine Division; Food and Nutrition Board; Committee to Review the Dietary Reference Intakes for Sodium and Potassium. Dietary Reference Intakes for Sodium and Potassium. Ed. by Oria M., Harrison M., Stallings V. A. Washington (DC), National Academies Press, 2019, 594 p. doi: 10.17226/25353</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ndrepepa G., Kastrati A. Gamma-Glutamyl Transferase and Cardiovascular Disease. Ann Transl Med. 2016, vol. 4, no. 24, p. 481. doi: 10.21037/atm.2016.12.27</mixed-citation><mixed-citation xml:lang="en">Ndrepepa G., Kastrati A. Gamma-Glutamyl Transferase and Cardiovascular Disease. Ann Transl Med. 2016, vol. 4, no. 24, p. 481. doi: 10.21037/atm.2016.12.27</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Parthiban G., Srivatsa S. Applying Machine Learning Methods in Diagnosing Heart Disease for Diabetic Patients. Intern. J. of Applied Information Systems. 2012, vol. 3, pp. 25–30.</mixed-citation><mixed-citation xml:lang="en">Parthiban G., Srivatsa S. Applying Machine Learning Methods in Diagnosing Heart Disease for Diabetic Patients. Intern. J. of Applied Information Systems. 2012, vol. 3, pp. 25–30.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">SahBandar I. N., Ndhlovu L. C., Saiki K., Kohorn L. B., Peterson M. M., D'Antoni M. L., Shiramizu B., Shikuma C. M., Chow D. C. Relationship between Circulating Inflammatory Monocytes and Cardiovascular Disease Measures of Carotid Intimal Thickness. J. of Atherosclerosis and Thrombosis. 2019, vol. 27, no. 5, pp. 1–8. doi: 10.5551/jat.49791</mixed-citation><mixed-citation xml:lang="en">SahBandar I. N., Ndhlovu L. C., Saiki K., Kohorn L. B., Peterson M. M., D'Antoni M. L., Shiramizu B., Shikuma C. M., Chow D. C. Relationship between Circulating Inflammatory Monocytes and Cardiovascular Disease Measures of Carotid Intimal Thickness. J. of Atherosclerosis and Thrombosis. 2019, vol. 27, no. 5, pp. 1–8. doi: 10.5551/jat.49791</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Semerdjian J., Frank S. An Ensemble Classifier for Predicting the Onset of Type II Diabetes. arXiv:1708.074802017. 2017. doi: 10.48550/arXiv.1708.07480</mixed-citation><mixed-citation xml:lang="en">Semerdjian J., Frank S. An Ensemble Classifier for Predicting the Onset of Type II Diabetes. arXiv:1708.074802017. 2017. doi: 10.48550/arXiv.1708.07480</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Teimouri M., Ebrahimi E., Alavinia M. Comparison of Various Machine Learning Methods in Diagnosis of Hypertension in Diabetics with/without Consideration of Costs. Iranian J. of Epidemiology. 2016, vol. 11, no. 4, pp. 46–54.</mixed-citation><mixed-citation xml:lang="en">Teimouri M., Ebrahimi E., Alavinia M. Comparison of Various Machine Learning Methods in Diagnosis of Hypertension in Diabetics with/without Consideration of Costs. Iranian J. of Epidemiology. 2016, vol. 11, no. 4, pp. 46–54.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">National Diabetes Statistics Report. Available at: https://www.cdc.gov/diabetes/data/statistics-report/index.html (accessed 15.01.2022)</mixed-citation><mixed-citation xml:lang="en">National Diabetes Statistics Report. Available at: https://www.cdc.gov/diabetes/data/statistics-report/index.html (accessed 15.01.2022)</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">National Center for Health Statistics. Available at: https://www.cdc.gov/nchs/index.htm (accessed 15.01.2022)</mixed-citation><mixed-citation xml:lang="en">National Center for Health Statistics. Available at: https://www.cdc.gov/nchs/index.htm (accessed 15.01.2022)</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Cardiovascular diseases (CVDs). Available at: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) (accessed 15.01.2022)</mixed-citation><mixed-citation xml:lang="en">Cardiovascular diseases (CVDs). Available at: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) (accessed 15.01.2022)</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Zeya L. T. Essential Things You Need to Know About F1-Score. Towards Data Science. Available at: https://towardsdatascience.com/essential-things-you-need-toknow-about-f1-score-dbd973bf1a3 (accessed 15.01.2022)</mixed-citation><mixed-citation xml:lang="en">Zeya L. T. Essential Things You Need to Know About F1-Score. Towards Data Science. Available at: https://towardsdatascience.com/essential-things-you-need-toknow-about-f1-score-dbd973bf1a3 (accessed 15.01.2022)</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">DerSarkissian C. Eosinophils and Eosinophil Count Test. Available at: https://www.webmd.com/asthma/eosinophil-count-facts#1 (accessed 15.01.2022)</mixed-citation><mixed-citation xml:lang="en">DerSarkissian C. Eosinophils and Eosinophil Count Test. Available at: https://www.webmd.com/asthma/eosinophil-count-facts#1 (accessed 15.01.2022)</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
